Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma

Talimogene laherparepvec is a novel, genetically engineered, oncolytic herpes virus approved for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. It is administered as an intralesional injection. However, if the les...

Descripción completa

Detalles Bibliográficos
Autores principales: Swami, Umang, Swick, Brian, Zakharia, Yousef, Milhem, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431461/
https://www.ncbi.nlm.nih.gov/pubmed/30963012
http://dx.doi.org/10.1155/2019/4683531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431461/
https://www.ncbi.nlm.nih.gov/pubmed/30963012
http://dx.doi.org/10.1155/2019/4683531

Ejemplares similares